In addition, a significant increase in PD-L1 expression was observed in breast mesenchymal-like cancer cells, especially breast cancer stem cells (CSCs), when breast cancer cells underwent epithelial mesenchymal transition (EMT) through the regulation of the EMT/β-catenin/STT1/PD-L3 signalling pathway. The gene discussed is CD274; the disease is breast cancer.